PR Newswire News
- 12:18:00
- MicroPort CRM Receives Approval in Japan for Alizea Bluetooth Pacemaker
2022-01-17
- 08:35:00
- CStone announces the clinical data from registrational study of Sugemalimab in stage III non-small cell lung cancer published in The Lancet Oncology
- 08:31:00
- CStone announces the registrational clinical study results of sugemalimab in stage IV non-small cell lung cancer published in The Lancet Oncology
2022-01-15
- 17:30:00
- ZTO Held 2022 Nationwide Network Conference
- 13:02:00
- GWM Hit a New Record in 2021 with 15% Sales Growth
- 08:00:00
- Everest Medicines Enters into a Global Licensing Agreement to Develop and Commercialize Singapore's Experimental Drug Development Centre's 3CL Protease Inhibitors as Potentially Best-in-Class COVID-19 Oral Antiviral Treatments Worldwide
2022-01-14
- 17:30:00
- Ascletis Announces First Patient Dosed in the Phase II Clinical Trial of FASN Inhibitor ASC40 for Treatment of Moderate to Severe Acne
- 16:00:00
- Reinventing NFT experience - Artemis Launched the World's First Decentralized Mobile-focused NFT Social & Trading Platform
- 14:30:00
- Priority Pass Announces Global Partnership with CarTrawler to Drive Frictionless Travel Experience
- 10:46:00
- Enrollment Completed in Phase II Clinical Study of KN026 Combined with KN046
- 10:00:00
- Telehouse set to expand presence in Southeast Asia with opening of the most connected data centre in Thailand
- 08:05:00
- CStone announces phase 2 GEMSTONE-201 trial met primary endpoint of objective response rate (ORR) in patients with relapsed or refractory extranodal natural killer/T-cell lymphoma (R/R ENKTL)
2022-01-13
- 22:52:00
- Over half of CEOs to step-up investment and M&A in 2022, but headwinds remain
- 22:00:00
- FarEye Joins Microsoft Cloud for Retail Ecosystem to Advance End-to-End Commerce Experience
- 20:53:00
- Infosys: Revenue guidance for FY22 revised upwards to 19.5%-20.0%, powered by sequential growth of 7.0% in Q3
- 20:32:00
- CICC's Dr. Huang Haizhou Receives the 19th Sun Yefang Economic Science Award
- 19:51:00
- CICC's Dr. Huang Haizhou Receives the 19th Sun Yefang Economic Science Award
- 16:38:00
- Mr. Ernest Lee elected as HKCGI President 2022
- 15:55:00
- IQAX expands in Mainland China to better serve clients and the industry
- 15:15:00
- Transcenta to Present Two Phase I Clinical Trials of TST001 at Upcoming ASCO GI and IGCC
2022-01-12
